Kibedi B. Cabral

Kibedi B. Cabral

Auto-generated profile, based on publicly available information

Kibedi B. Cabral

Departement of Biochemistry, Medical Faculty, Kabale University, Uganda

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2024 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
DSDwi Saryanti
Dwi Saryanti
MDMuhammad Da’i
Muhammad Da’i
KCKibedi B. Cabral
Kibedi B. Cabral
EWErindyah Retno Retno Wikantyasning
Erindyah Retno Retno Wikantyasning
Men with Erectile Dysfunction (ED) experience difficulty in initiating or sustaining a firm erection during sexual engagement. Pharmacological agents, commonly referred to as aphrodisiacs, effectively treat erectile dysfunction. Aphrodisiac drugs, whether synthetic or herbal, have limited bioavailability, leading to reduced oral absorption. Particle size reduction strategies can address this issue. Nanosize demonstrated a substantial enhancement in oral and transdermal bioavailability when using nanoparticles composed of pure components. The use of nanoparticles at the prescribed dosage is considered safe, and when applied to the skin in a transdermal manner, they do not exhibit any signs of irritation or histopathological alterations, making them suitable for skin application. Furthermore, nanoparticles enable the control, sustenance, and prolongation of drug release.

15 June 2025 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
PIPeni Indrayudha
Peni Indrayudha
FWFebri Wulandari
Febri Wulandari
KCKibedi Cabral
Kibedi Cabral
MGMuhammad Ia Af Ghani
Muhammad Ia Af Ghani
Objective: Pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, are sources of infectious diseases. It is known that Nigella sativa contains nigellimine, nigellimine-N-oxide, nigellidine, and nigellicine, as well as other active alkaloid compounds. The purpose of this study was to examine the antibacterial activity and bioautography of the ethyl acetate fraction of Nigella sativa against Bacillus cereus, Shigella sonnei, Streptococcus mutans, and Klebsiella pneumoniae. Methods: Thin Layer Chromatography (TLC) was used in the bioautography analysis, and the disc diffusion technique was used to test the antibacterial activity. The concentrations of the ethyl acetate fractions were 20%, 40%, 60%, and 80%. Results: The ethyl acetate fraction of Nigella sativa showed strong antibacterial activity against a number of microorganisms studied. According to the data, the inhibition zone was the best at a concentration of 80%. The diameters of the inhibition zones for the following bacteria were measured: 11.08±0.38 mm for Klebsiella pneumoniae, 12.50±0.50 mm for Shigella sonnei, and 17.67±0.58 mm for Bacillus cereus, covering a disc diameter of 6.00 mm. The findings of the bioautography test indicated that the alkaloid component is most likely the active ingredient causing the antibacterial activity. Conclusion: Based on this research, the ethyl acetate fraction of Nigella sativa can be used as a natural antibacterial agent.